immune system
|
• severely enlarged by 16 weeks
|
|
• increased in spleen relative to Faslpr homozygotes
|
|
• lower in spleen and lymph node compared to wild-type or single mutants
|
|
• mice show reduced amount of nae T cells compared to wild-type or Bcl2l11-deficient mice
• no difference in number of regulatory T cells is observed
|
|
• T cell subpopulations in the spleen and lymph nodes including single-positive, central memory and effector memory T cells are increased compared to single-deficient mice
|
|
• increased memory T cell numbers in spleen and lymph nodes relative to single mutant animals
|
|
• number of CD45+ cells is increased 4.6-fold vs wild-type, 3.2-fold vs Faslpr homozygotes, and 2.8-fold vs Bcl2l11-deficient mice
|
|
• plasmablast numbers in spleen are increased 30-fold relative to wild-type, 2-fold relative to Bcl2l11-deficient and 4-fold relative to Faslpr homozygous mice
|
|
• number of T1 and T2 B cells is increased relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• higher in spleen relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• higher in spleen relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• increased numbers in spleen and lymph nodes are observed
|
|
• increased effector memory T cell numbers in spleen and lymph nodes relative to single mutant animals
|
|
• enlargement of spleen is accompanied by alteration of spleen architecture, characterized by decreased red pulp amount
|
|
• enlargement of spleen is accompanied by alteration of spleen architecture, characterized by increased white pulp amount
|
|
• T1:follicular B cell ratio is disturbed; ratio is higher significantly higher than wild-type, Bcl2l11-deficient mice or Faslpr homozygotes
• increased B cell number; CD19+ B cells are increased by 4.3-fold over wild-type, 1.8-fold over Bcl2l11-null mice and by 3.6-fold over Faslpr mice
|
|
• CD19+ B cells are increased 2.2-fold over wild-type and Bcl2l11-deficient mice
• no difference from B cell number in Faslpr mice
|
|
• severely enlarged by 16 weeks
|
|
• on a normally resistant background, mice develop extreme lymphadenopathy and SLE
|
|
• total anti-IgM and total anti-IgG antibody levels are increased compared to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice; anti-nuclear, anti-cytoplasmic and anti-glomerular antibodies are increased relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• anti-nuclear antibodies are increased compared to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• anti-dsDNA IgM and IgG antibodies are increased compared to wild-type and Bcl2l11-deficient mice; anti-dsDNA IgM antibody levels are increased over levels in Faslpr homozygotes
|
|
• increased compared to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• anti-ssDNA IgM and IgG antibodies are increased compared to wild-type and Bcl2l11-deficient mice; anti-ssDNA IgM antibody levels are increased over levels in Faslpr homozygotes
|
hematopoietic system
|
• severely enlarged by 16 weeks
|
|
• increased in spleen relative to Faslpr homozygotes
|
|
• lower in spleen and lymph node compared to wild-type or single mutants
|
|
• mice show reduced amount of nae T cells compared to wild-type or Bcl2l11-deficient mice
• no difference in number of regulatory T cells is observed
|
|
• T cell subpopulations in the spleen and lymph nodes including single-positive, central memory and effector memory T cells are increased compared to single-deficient mice
|
|
• increased memory T cell numbers in spleen and lymph nodes relative to single mutant animals
|
|
• number of CD45+ cells is increased 4.6-fold vs wild-type, 3.2-fold vs Faslpr homozygotes, and 2.8-fold vs Bcl2l11-deficient mice
|
|
• plasmablast numbers in spleen are increased 30-fold relative to wild-type, 2-fold relative to Bcl2l11-deficient and 4-fold relative to Faslpr homozygous mice
|
|
• number of T1 and T2 B cells is increased relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• higher in spleen relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• higher in spleen relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• increased numbers in spleen and lymph nodes are observed
|
|
• increased effector memory T cell numbers in spleen and lymph nodes relative to single mutant animals
|
|
• enlargement of spleen is accompanied by alteration of spleen architecture, characterized by decreased red pulp amount
|
|
• enlargement of spleen is accompanied by alteration of spleen architecture, characterized by increased white pulp amount
|
|
• T1:follicular B cell ratio is disturbed; ratio is higher significantly higher than wild-type, Bcl2l11-deficient mice or Faslpr homozygotes
• increased B cell number; CD19+ B cells are increased by 4.3-fold over wild-type, 1.8-fold over Bcl2l11-null mice and by 3.6-fold over Faslpr mice
|
renal/urinary system
|
• higher numbers of apoptotic cells are detected in glomeruli compared to wild-type and single mutant mice
|
|
• glomerular proliferation is increased
|
|
• significant increase in renal B cells (CD19+) compared to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
• number of macrophages surrounding glomeruli is increased compared to wild-type and Faslpr homozygotes; macrophage index is 2.5-fold higher than in Fas homozygotes
|
|
• IgG deposits mainly localized to basement glomerular membrane are increased relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
|
• glomerular basement membrane thickening
|
|
• mesangial expansion, basement membrane thickening, increased interstitial infiltration, and loss of open capillary loops are characteristic hallmarks of renal damage observed
• kidney damage pathological scores are increased over wild-type, Faslpr homozygotes, and Bcl2l11-deficient glomeruli
• glomerular proliferation is increased
|
|
• loss of open capillary loops
|
|
• mesangial expansion
|
|
• glomerular size is increased relative to wild-type, Faslpr homozygotes, and Bcl2l11-deficient mice
|
cellular
|
• higher numbers of apoptotic cells are detected in glomeruli compared to wild-type and single mutant mice
|
|
• glomerular proliferation is increased
|
cardiovascular system
|
• loss of open capillary loops
|
growth/size/body
|
• severely enlarged by 16 weeks
|


Analysis Tools